2024 annual financial data

Tonix Pharmaceuticals Holding 2024 Net margin

Direct answer

Net margin was -1,288.25%.

Operating income was -136,701,000 USD and net income was -130,036,000 USD.
Operating cash flow was -60,925,000 USD.

Get free Tonix Pharmaceuticals Holding email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
10,094,000 USD
Operating income
-136,701,000 USD
Net income
-130,036,000 USD
Operating cash flow
-60,925,000 USD